The Line
The Line is a Canadian magazine dedicated to covering local, national and international politics, news, current events and occasionally some obscure stories. Hosted by Matt Gurney and Jen Gerson.
The Line
Is Alberta hurtling toward the edge?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode of On The Line, host Jen Gerson sits down with Jared Wesley and Ken Boessenkool, two members of the Lead Not Leave initiative, for a conversation about the current state of Alberta separatism and the province’s uncertain political future.
This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit. This summer, BioCanRx and The Line have been talking about potential solutions for the problems that are limiting Canada’s ability to domestically develop new drugs, especially immunotherapies for cancer. We ask a lot of Canadian cancer researchers. The work required to discover new therapies for numerous diseases, and get them to patients, costs far more than the half-billion dollars invested in cancer research by all levels of government and charities –– and often the available grants specialize in only one part of the spectrum: discovery. We need to be sure we're supporting researchers at every step of this complex scientific and regulatory process. BioCanRx has proved you can meaningfully support this part. The entire team is only 12 people, but they know what it takes to do things like submit a clinical trial application or safely manufacture a drug, so the researchers they fund are held to firm, realistic standards that make sense in the real world of Canadian health-care systems and industry. That’s how a tiny not-for-profit has helped bring 16 new drugs to clinical trials that have treated more than 400 people in just 10 years. But research is only one part of the puzzle — can we manufacture new therapies in Canada? More on that next time. Visit BioCanRx.com to learn more.
While recent polling has suggested that support for outright separation may be softer than some headlines imply, neither Wesley nor Boessenkool is particularly sanguine about the outcome of the coming referendum campaign. They argue that low turnout and voter suppression could produce a result that overstates support for separatism, creating a misleading picture of where Albertans actually stand.
The discussion also examines the changing relationship between Alberta and Ottawa, and whether recent improvements between the provincial and federal governments have meaningfully reduced the political grievances that have fuelled separatist sentiment. They explore the concept of moral hazard in Canadian federalism, the incentives facing provincial leaders, and whether those dynamics are helping—or hurting—the cause of national unity.
This episode is also brought to you by the Forest Products Association of Canada. Canada’s resilience will not be built through diversified trade and good intentions alone. It will be built with strong domestic supply chains, reliable Canadian materials, and industries that invest in workers and communities here at home.Two months ago, the federal government acknowledged the Forest Sector Transformation Task Force Report and the practical path it set out. Now the focus must be action. Canada’s forest products sector can help deliver the homes, infrastructure, and economic potential the country needs. But that requires predictable access to manage our forests, transportation systems that work, and a regulatory environment that rewards investment rather than delays it. The direction is clear. Now Ottawa needs to turn recognition into results.Learn more at FPAC.ca.
Finally, Gerson asks what happens after the vote. Whatever the result, will the United Conservative Party be able to hold together, or are the internal tensions that have defined Alberta conservatism for years becoming too great to contain?
As always, check out our main page at ReadTheLine.ca — and never, ever forget to like and subscribe!
This episode is brought to you by Cameco. In nuclear energy, timelines and costs matter. Incomplete designs carry real risk of delays and cost overruns. That’s why the AP1000 reactor is the right choice for Canada: it is already operating today and ready now to deliver the power we need, with 100 percent Canadian ownership and strong participation from Canadian suppliers. If we are serious about building Canada and powering it on time and on budget, the choice is clear. The AP1000 reactor is the only option that delivers.To learn more, visit ap1000.cameco.com.
#OnTheLine #Alberta #AlbertaPolitics #Separatism #LeadNotLeave #JaredWesley #KenBoessenkool #CanadaPolitics #JenGerson #TheLinePodcast